These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 25104635

  • 1. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R.
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G, Paing AZ, Myint NN, Di W, Thu KH, Ram M, Hoffmann CJ, Wang B, Naing S.
    J Int AIDS Soc; 2016 Jan; 19(1):20926. PubMed ID: 27784509
    [Abstract] [Full Text] [Related]

  • 4. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.
    Bussmann H, Wester CW, Ndwapi N, Grundmann N, Gaolathe T, Puvimanasinghe J, Avalos A, Mine M, Seipone K, Essex M, Degruttola V, Marlink RG.
    AIDS; 2008 Nov 12; 22(17):2303-11. PubMed ID: 18981769
    [Abstract] [Full Text] [Related]

  • 5. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A, AIDS Working Group of MSF.
    JAMA; 2010 Jul 21; 304(3):303-12. PubMed ID: 20639564
    [Abstract] [Full Text] [Related]

  • 6. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H, Nicholas S, Tang Z, Szumilin E, Balkan S, Pujades-Rodriguez M.
    Trop Med Int Health; 2012 Oct 21; 17(10):1255-63. PubMed ID: 22863110
    [Abstract] [Full Text] [Related]

  • 7. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.
    J Infect Dis; 2013 Jan 01; 207(1):72-9. PubMed ID: 23100567
    [Abstract] [Full Text] [Related]

  • 8. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS.
    Ann Intern Med; 2011 Aug 16; 155(4):209-16. PubMed ID: 21768555
    [Abstract] [Full Text] [Related]

  • 9. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.
    Bekker LG, Myer L, Orrell C, Lawn S, Wood R.
    S Afr Med J; 2006 Apr 16; 96(4):315-20. PubMed ID: 16670804
    [Abstract] [Full Text] [Related]

  • 10. Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013.
    Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R.
    AIDS; 2016 Jan 28; 30(3):477-85. PubMed ID: 26636931
    [Abstract] [Full Text] [Related]

  • 11. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, Spoerri A, Chimbwandira F, van Oosterhout JJ, Keiser O.
    Lancet HIV; 2016 Apr 28; 3(4):e175-82. PubMed ID: 27036993
    [Abstract] [Full Text] [Related]

  • 12. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, Keiser O, IeDEA Southern Africa.
    Trop Med Int Health; 2012 Dec 28; 17(12):1509-20. PubMed ID: 22994151
    [Abstract] [Full Text] [Related]

  • 13. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD, Sikombe K, Eshun-Wilson I, Sikazwe I, Glidden DV, Pry JM, Somwe P, Beres LK, Simbeza S, Mwamba C, Bukankala C, Hantuba C, Moore CB, Holmes CB, Padian N, Geng EH.
    PLoS Med; 2020 May 28; 17(5):e1003107. PubMed ID: 32401797
    [Abstract] [Full Text] [Related]

  • 14. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.
    AIDS; 2007 Nov 30; 21(18):2483-91. PubMed ID: 18025885
    [Abstract] [Full Text] [Related]

  • 15. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D, STOPAR study team.
    Antivir Ther; 2013 Nov 30; 18(1):125-30. PubMed ID: 22805174
    [Abstract] [Full Text] [Related]

  • 16. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.
    AIDS; 2006 May 12; 20(8):1181-9. PubMed ID: 16691070
    [Abstract] [Full Text] [Related]

  • 17. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M, Johnson LF, Wood R, Tanser F, Fox MP, Prozesky H, Schomaker M, Egger M, Davies MA, Boulle A, International Epidemiology Databases to Evaluate AIDS-Southern Africa collaborationCentre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.Health Impact Assessment, Provincial Government of the Western Cape, Western Cape, South Africa..
    J Int AIDS Soc; 2017 Sep 25; 20(1):21902. PubMed ID: 28953328
    [Abstract] [Full Text] [Related]

  • 18. Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda.
    Castelnuovo B, Kiragga A, Musaazi J, Sempa J, Mubiru F, Wanyama J, Wandera B, Kamya MR, Kambugu A.
    PLoS One; 2015 Sep 25; 10(12):e0142722. PubMed ID: 26642214
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP, Stratall ANRS 12110/ESTHER Study Group.
    Lancet Infect Dis; 2013 Jul 25; 13(7):577-86. PubMed ID: 23602084
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
    Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kazé S, Molinari N, Bourgeois A, Mpoudi-Ngolé E, Spire B, Koulla-Shiro S, Delaporte E, Stratall ANRS 12110/ESTHER study group.
    Lancet Infect Dis; 2011 Nov 25; 11(11):825-33. PubMed ID: 21831714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.